Alector, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Alector, Inc. (ALEC) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $3.92 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-25
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.92M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.49M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.56M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $13.01M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $3.92M 10-K · filed 2026-02-25 |
| 2024-12-31 | $6.49M 10-K · filed 2025-02-26 |
| 2023-12-31 | $9.56M 10-K · filed 2024-02-27 |
| 2022-12-31 | $13.01M 10-K · filed 2023-02-28 |
| 2021-12-31 | $16.91M 10-K · filed 2022-02-24 |
| 2020-12-31 | $21.12M 10-K · filed 2021-02-25 |
| 2019-12-31 | $23.64M 10-K · filed 2020-03-24 |
| 2019-09-30 | $24.69M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $25.74M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $26.79M 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |